407640-21-5

Usage

Uses

Used in Pharmaceutical Industry:
3-(Methanesulfonylamino)phenylacetic acid is used as a potential anti-inflammatory and analgesic agent for its ability to reduce inflammation and alleviate pain.
Used in Oncology:
3-(Methanesulfonylamino)phenylacetic acid is used in the treatment of cancer due to its potential to target and inhibit the growth of cancer cells, making it a promising candidate for further research in oncology.
Used in Medicinal Chemistry Research:
3-(Methanesulfonylamino)phenylacetic acid is used as a starting material or intermediate in the synthesis of new pharmaceuticals, leveraging its unique structure and properties to develop innovative drugs with improved therapeutic effects.

Upstream product

• 692890-39-4 2-(3-(methylsulfonylamino)phenyl)acetic acid methyl ester 

Downstream Products

• 692885-22-6 C₁₇H₁₆N₄O₃S₂ 
• 66340-79-2 (3-Methanesulfonylamino-phenyl)-[(Z)-methoxyimino]-acetic acid 
• 916765-79-2 N-[3-(2-oxo-2-thioureido-ethyl)-phenyl]-methanesulfonamide 
• 61560-93-8 2-(3-Mesylaminophenyl)glyoxylic acid 

Relevant academic research and scientific papers

Compounds and Compositions as Channel Activating Protease Inhibitors

The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.

AZAINDOLES USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES

The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES

The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES

The present invention relates to substitute thiazole and thiophene derivatives useful as inhibitors of rock and other protein kinaeses. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders, including proliferative, cardiac and neurodegenerative diseases.